Over the last 12 months, three Turn Therapeutics Inc. insiders added shares in open-market trades, about $308,000 in total, and none of them sold.
Biggest single buyer: GOLDEN ARTHUR F, Director, with roughly $100,000.
Big money check: 29 institutions held TTRX as of Q2 2026, and more funds bought than sold. Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Chaudhary Zuraiz | Officer | Buy | 2,500 | $3.50 | $9K | SEC |
| Nov 25, 2025 | GOLDEN ARTHUR F | Director | Buy | 9,868 | $3.44 | $34K | SEC |
| Nov 24, 2025 | GOLDEN ARTHUR F | Director | Buy | 20,532 | $2.87 | $59K | SEC |
| Nov 21, 2025 | Chaudhary Zuraiz | Officer | Buy | 1,450 | $2.61 | $4K | SEC |
| Nov 21, 2025 | Chaudhary Zuraiz | Officer | Buy | 1,000 | $3.29 | $3K | SEC |
| Nov 17, 2025 | Chaudhary Zuraiz | Officer | Buy | 2,500 | $3.62 | $9K | SEC |
| Oct 29, 2025 | Chesed Abraham | Other | Buy | 14,286 | $4.60 | $66K | SEC |
| Oct 23, 2025 | Chaudhary Zuraiz | Officer | Buy | 5,050 | $4.95 | $25K | SEC |
| Oct 23, 2025 | GOLDEN ARTHUR F | Director | Buy | 20,202 | $4.95 | $100K | SEC |
In the last 12 months Turn Therapeutics Inc. insiders made open-market purchases worth about $308,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in TTRX was filed on 2025-12-12.
29 investment managers reported holding TTRX in SEC Form 13F filings for Q2 2026.
No congressional trades in TTRX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).